Investing Ideas
/
Polish Pharmaceuticals & Biotech Price disconnect

Polish Pharmaceuticals & Biotech Price disconnect

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

1 companies

Genomed Spólka Akcyjna

Market Cap: zł32.5m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł25.40

-1.6%